Short-term effect of parathyroidectomy on biochemical markers in primary and secondary hyperparathyroidism

Mineral and Electrolyte Metabolism

Volumn 23, Issue 2, 1997, Pages 93-99

  Hoshino, Hironobu ^a   Kushida, Kazuhiro ^a   Takahashi, Masaaki ^a   Denda, Masashi ^a   Yamazaki, Kaoru ^a   Yamanashi, Akihiro ^a   Inoue, Tetsuo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Biochemical markers; Bone formation; Bone resorption; Hyperparathyroidism; Parathyroidectomy

Indexed keywords

BIOCHEMICAL MARKER; DEOXYPYRIDINOLINE; OSTEOCALCIN; PARATHYROID HORMONE; PROCOLLAGEN; PYRIDINOLINE;

ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD ANALYSIS; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; IMMUNORADIOMETRIC ASSAY; MALE; PARATHYROIDECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; URINALYSIS;

AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; AMINO ACIDS; BIOLOGICAL MARKERS; BONE DENSITY; FEMALE; HUMANS; HYPERPARATHYROIDISM; HYPERPARATHYROIDISM, SECONDARY; KINETICS; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROIDECTOMY; PEPTIDE FRAGMENTS; PROCOLLAGEN;

EID: 0030740197     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Delmas PD, Demiaux B, Malaval L, Chapuy MC, Edouard C, Meunier PJ: Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. J Clin Invest 1986;77: 985-991.
2. Parisien M, Silverberg SJ, Shane E, De La Cruz L, Lindsay R, Bilezikian JP, Dempster DW: The histomorphometry of bone in primary hyperparathyroidism: Preservation of cancellous bone structure. J Clin Endocrinol Metab 1990; 70:930-938.
3. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM: Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1994;40:358-363.
4. Takahashi M, Ohishi T, Aoshima H, Kushida K, Inoue T, Horiuchi K: Pre-fractionation with cation exchanger for determination of intermolecular cross-links, pyridinoline and pentosidine, in hydrolysate. J Liquid Chromatogr 1993; 16:1355-1370.
5. Minisola S, Romagnoli E, Scarnecchia L, Rosso R, Pacitti MT, Scarda A, Mazzuoli G: Serum carboxy-terminal propeptide of human type I procollagen in patients with primary hyperparathyroidism: Studies in basal conditions and after parathyroid surgery. Eur J Endocrinol 1994;130:587-591.
6. Delmas PD, Wilson DM, Mann KG, Riggs BL: Effect of renal function on plasma levels of bone Gla-protein. J Clin Endocrinol Metab 1983;57:1028-1030.
7. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J: Serum markers of type I collagen formation and degradation in metabolic bone disease: Correlation with bone histomorphometry. J Bone Miner Res 1993;8:127-132.
8. Seibel MJ, Gartenberg F, Silverberg SJ, Ratcliffe A, Robins SP, Bilezikian JP: Urinary hydroxypyridinium cross-links of collagen as indices of bone resorption in primary hyperparathyroidism. J Bone Miner Res 1990; 5(suppl 2):666A.
9. Charles P, Hasling C, Risteli L, Risteli J, Mosekilde L, Eriksen EF: Assessment of bone formation by biochemical markers in metabolic bone disease: Separation between osteoblastic activity at the cell and tissue level. Calcif Tissue int 1992;51:406-411.
10. Coen G, Mazzaferro S, De Antoni E, Chicca S, DiSanza, P, Onorato L, Spurio A, Sardella D, Trombetta M, Manni M, Pasquali M: Procollagen type I C-terminal extension peptide serum levels following parathyroidectomy in hyperparathyroid patients. Am J Nephrol 1994; 14:106-112.
11. Price PA, Baukol SA:1,25-Dihydroxyvitamin D3 increases synthesis of the vitamin K-dependent bone protein by osteosarcoma cells. J Biol Chem 1980;255:11660-11663.
12. Yoneda M, Takatsuki K, Yamauchi K, Oiso Y, Kurokawa M, Kawakubo A, Torimoto Y, Funahashi H, Tomita A: Effect of parathyroid function on serum bone gla protein. Endocrinol Jpn 1988;35:39-45.
13. 3, parathyroid hormone and glucocorticosteroids. Metab Bone Dis Relat Res 1984;5:229-234.
14. 3 administration on serum bone GLA protein in predialysis chronic renal failure. Adv Exp Med Biol 1986;208:297-303.